PT Surya Citra Media Tbk (IDX:SCMA)

Theseus Pharmaceuticals Balance Sheet

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,451,934	2,527,538	634,488	2,330,538	3,232,181	677,880
Short-Term Investments	106,963	287,145	1,934,419	247,686	87,888	72,999
Trading Asset Securities	154,738	151,486	300,219	-	-	-
Cash & Short-Term Investments	1,713,635	2,966,169	2,869,126	2,578,224	3,320,069	750,879
Cash Growth	-44.70%	3.38%	11.28%	-22.34%	342.16%	19.41%
Accounts Receivable	1,845,513	1,967,331	2,275,923	2,292,150	1,952,542	1,853,245
Other Receivables	356,293	372,823	374,237	356,760	92,236	49,734
Receivables	2,201,806	2,340,154	2,650,159	2,648,910	2,044,778	1,902,979
Inventory	1,275,476	1,172,889	1,205,587	1,096,641	783,593	670,618
Prepaid Expenses	579,403	442,106	309,098	250,168	123,953	99,836
Other Current Assets	254,075	331,013	393,136	1,055,190	387,964	184,729
Total Current Assets	6,024,394	7,252,332	7,427,106	7,629,133	6,660,356	3,609,041
Property, Plant & Equipment	1,925,896	1,981,348	1,946,995	1,786,217	1,677,198	1,616,234
Long-Term Investments	163,258	147,322	115,248	156,295	121,189	120,061
Goodwill	614,446	619,098	619,098	619,098	619,098	614,609
Other Intangible Assets	487,918	493,974	548,450	588,550	593,520	632,480
Long-Term Deferred Tax Assets	112,994	121,251	129,519	116,034	24,501	39,190
Other Long-Term Assets	302,540	199,927	266,089	179,805	217,579	135,288
Total Assets	9,631,446	10,815,251	11,052,506	11,075,132	9,913,441	6,766,903
Accounts Payable	386,149	479,296	579,712	576,919	491,938	351,952
Accrued Expenses	778,466	1,129,314	1,163,999	791,908	572,333	525,755
Current Portion of Long-Term Debt	14,927	7,613	4,373	295,202	1,460	197,760
Current Portion of Leases	3,602	5,949	6,253	6,547	5,603	3,536
Current Income Taxes Payable	59,882	41,753	74,730	55,910	162,759	160,469
Other Current Liabilities	434,779	533,600	449,146	356,489	463,604	303,002
Total Current Liabilities	1,677,804	2,197,525	2,278,214	2,082,975	1,697,697	1,542,475
Long-Term Debt	-	-	-	-	600,000	1,114,588
Long-Term Leases	6,572	6,572	9,174	2,745	5,748	8,181
Long-Term Deferred Tax Liabilities	99,671	99,665	110,937	129,469	-	-
Total Liabilities	1,954,633	2,459,005	2,569,934	2,365,836	2,452,264	2,870,317
Common Stock	739,706	739,706	739,706	739,706	739,706	738,955
Additional Paid-In Capital	407,498	407,498	423,804	450,145	449,446	424,746
Retained Earnings	6,049,219	6,870,916	6,909,756	6,985,995	6,297,653	4,950,188
Treasury Stock	-2,833,490	-2,833,490	-2,862,929	-2,912,545	-2,912,545	-2,865,407
Comprehensive Income & Other	2,288,760	2,298,700	2,278,424	2,279,964	1,813,940	23,722
Total Common Equity	6,651,693	7,483,330	7,488,760	7,543,263	6,388,199	3,272,204
Minority Interest	1,025,120	872,917	993,812	1,166,032	1,072,978	624,383
Shareholders' Equity	7,676,813	8,356,247	8,482,572	8,709,296	7,461,177	3,896,587
Total Liabilities & Equity	9,631,446	10,815,251	11,052,506	11,075,132	9,913,441	6,766,903
Total Debt	25,101	20,133	19,800	304,494	612,811	1,324,065
Net Cash (Debt)	1,688,534	2,946,036	2,849,326	2,273,730	2,707,258	-573,186
Net Cash Growth	-45.27%	3.39%	25.31%	-16.01%	-	-
Net Cash Per Share	26.62	46.49	45.08	35.97	42.83	-8.08
Filing Date Shares Outstanding	63,467	63,467	63,369	63,207	63,207	63,253
Total Common Shares Outstanding	63,467	63,467	63,369	63,207	63,207	63,253
Working Capital	4,346,590	5,054,807	5,148,893	5,546,158	4,962,660	2,066,566
Book Value Per Share	104.80	117.91	118.18	119.34	101.07	51.73
Tangible Book Value	5,549,329	6,370,258	6,321,212	6,335,616	5,175,580	2,025,115
Tangible Book Value Per Share	87.44	100.37	99.75	100.24	81.88	32.02
Land	1,000,994	995,141	923,110	907,225	903,546	903,278
Buildings	686,363	674,988	616,564	575,469	543,628	527,796
Machinery	2,788,301	2,763,692	2,641,440	2,457,735	2,206,116	2,000,690
Construction In Progress	35,462	33,678	40,069	23,368	8,217	36

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.